Coronary artery stenosis

Ian Weir1

  • 1London Chest Hospital, Bonner Road, London E2 9JX, UK. ian.weir@mac.com

Insights

Percutaneous coronary intervention (PCI) is rising, impacting coronary artery bypass grafting (CABG) referrals. Evidence suggests CABG remains superior for complex coronary artery disease, but long-term data is needed.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Medical Technology Assessment

Background:

  • The increasing use of percutaneous coronary intervention (PCI) has led to a decline in coronary artery bypass grafting (CABG) referrals, creating a crisis in cardiac surgery.
  • This shift raises questions about the future of CABG, a historically successful surgical procedure.
  • The implications extend to healthcare service provision, surgical training, and informed patient consent.

Purpose of the Study:

  • To present the arguments for the increasing pre-eminence of PCI in treating coronary artery disease.
  • To critically evaluate the evidence base comparing PCI and CABG, particularly for complex coronary artery disease.
  • To advocate for a multidisciplinary approach in selecting treatment options for patients with coronary artery disease.

Main Methods:

  • Review and synthesis of existing data and evidence comparing PCI and CABG.
  • Analysis of the strengths and weaknesses of current comparative studies.
  • Presentation of arguments from proponents of both PCI and CABG.

Main Results:

  • Percutaneous coronary intervention (PCI) has seen exponential growth in treating coronary artery disease.
  • Evidence strongly favors coronary artery bypass grafting (CABG) for triple vessel and left main coronary disease.
  • Concerns exist regarding the lack of long-term outcome data for PCI and methodological limitations in comparative studies.

Conclusions:

  • The dominance of PCI over CABG is increasing, but its long-term validity requires further investigation.
  • Further evidence is needed to determine if the current trend of PCI dominance over CABG will be vindicated.
  • A multidisciplinary approach to patient treatment options is advocated, but its implementation remains uncertain.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...